515 filings
Page 5 of 26
8-K
d7ezb133tz
1 Nov 18
Other Events
9:30am
8-K
cyaz5wpketpg gsa
16 Oct 18
Changes in Control of Registrant
4:05pm
8-K
8p7z q8m9
12 Oct 18
Departure of Directors or Certain Officers
4:18pm
424B3
z7rhpvxm
9 Oct 18
Prospectus supplement
4:16pm
8-K
2htl1rq 5t
28 Sep 18
Entry into a Material Definitive Agreement
4:00pm
424B3
ne2l3 34did4ul
21 Sep 18
Prospectus supplement
4:16pm
8-K
s5z9ymv07l61lr o18p
7 Sep 18
Entry into a Material Definitive Agreement
12:00am
D
xpdm9vcqkhmbqd7lu 8d
17 Aug 18
$5.14M in equity, sold $5.14M, 13 investors
4:42pm
8-K
o9jhxg h0qcl3tp
3 Aug 18
Entry into a Material Definitive Agreement
9:30am
424B3
404y cswak
3 Aug 18
Prospectus supplement
9:16am
8-K
ku3gl2je2n 3kznf
5 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K
db3xue1q8rt5
14 May 18
GT Biopharma Announces DR. Raymond W Urbanski Elevated to President and Chief Medical Officer of the Company
4:01pm
8-K
dn5scja mh
27 Apr 18
Former Sucampo Chief Scientific Officer, Dr. Peter Kiener, Joins GT Biopharma's Board of Directors
4:01pm
EFFECT
mh8vypwfjfvf9ikh6m
22 Mar 18
Notice of effectiveness
12:00am
EFFECT
45v4nl2d6b
22 Mar 18
Notice of effectiveness
12:00am
CORRESP
9tybv
21 Mar 18
Correspondence with SEC
12:00am
CORRESP
5e2yse
21 Mar 18
Correspondence with SEC
12:00am